Integra LifeSciences completes purchase of J&J’s Codman Neurosurgery
OCTOBER 2, 2017

Integra LifeSciences (Nasdaq: IART) has completed its previously announced $1.045 billion purchase of
Johnson & Johnson’s Codman Neurosurgery business, the companies announced today.